Drug reprofiling history and potential therapies against Parkinson’s disease

Komal Latif, Aman Ullah, Anastasiia D. Shkodina*, Dmytro I. Boiko, Zakia Rafique, Badrah S. Alghamdi, Mohamed A. Alfaleh, Ghulam Md Ashraf*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)

Abstract

Given the high whittling down rates, high costs, and moderate pace of new medication, revelation, and improvement, repurposing “old” drugs to treat typical and uncommon illnesses is progressively becoming an appealing proposition. Drug repurposing is the way toward utilizing existing medications in treating diseases other than the purposes they were initially designed for. Faced with scientific and economic challenges, the prospect of discovering new medication indications is enticing to the pharmaceutical sector. Medication repurposing can be used at various stages of drug development, although it has shown to be most promising when the drug has previously been tested for safety. We describe strategies of drug repurposing for Parkinson’s disease, which is a neurodegenerative condition that primarily affects dopaminergic neurons in the substantia nigra. We also discuss the obstacles faced by the repurposing community and suggest new approaches to solve these challenges so that medicine repurposing can reach its full potential.

Original languageEnglish
Article number1028356
JournalFrontiers in Pharmacology
Volume13
DOIs
Publication statusPublished - 26 Oct 2022
Externally publishedYes

Keywords

  • central nervous system
  • drug discovery
  • drug repurposing
  • neurodegeneration
  • Parkinson’s disease

Fingerprint

Dive into the research topics of 'Drug reprofiling history and potential therapies against Parkinson’s disease'. Together they form a unique fingerprint.

Cite this